Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2012
11/08/2012US20120283184 Inhibitors of type 2 vascular endothelial growth factor receptors
11/08/2012US20120283183 Method of reducing cell death by administering a paracrine factor of a mesenchymal stem cell
11/08/2012US20120283182 Peptide Modulators of the deltaPKC Interaction with the d Subunit of F1F0 ATP Synthase/ATPase and Uses Thereof
11/08/2012US20120283181 Crystal forms of saxagliptin and processes for preparing same
11/08/2012US20120283180 Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
11/08/2012US20120283179 Pharmaceutical composition comprising a glp-1 agonist and methionine
11/08/2012US20120283178 Learning motivation improvers
11/08/2012US20120283177 Novel schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (hiv)
11/08/2012US20120283176 Short fatty acid tail polymyxin derivatives and uses thereof
11/08/2012US20120283175 Antibacterial compositions
11/08/2012US20120283174 Antibiofilm glycopeptides
11/08/2012US20120283173 Novel compositions for treating pseudomonas infection
11/08/2012US20120283172 Modified porcine somatotropin polypeptides and their uses
11/08/2012US20120283171 Modified bovine somatotropin polypeptides and their uses
11/08/2012US20120283170 Acylated Exendin-4 Compounds
11/08/2012US20120283169 Pharmaceutical composition, methods for treating and uses thereof
11/08/2012US20120283168 Template-fixed peptidomimetics with ccr10 antagonistic activity
11/08/2012US20120283167 Ev576 for use in the treatment of viral infections of the respiratory tract
11/08/2012US20120283166 Peptide prodrugs
11/08/2012US20120282622 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
11/08/2012US20120282464 Spherical Protein Particles and Methods of Making and Using Them
11/08/2012US20120282343 Compositions for oral gene therapy and methods of using same
11/08/2012US20120282336 Bilayer tablet formulations
11/08/2012US20120282324 Methods for Promoting the Revascularization and Reenervation of CNS Lesions
11/08/2012US20120282322 Cochleate compositions directed against expression of proteins
11/08/2012US20120282320 Hemostatic dressing
11/08/2012US20120282305 Biological surfactants for connection to silicone-based materials and modulating levels of immunologically active proteins
11/08/2012US20120282302 Biomaterial composite composition and method of use
11/08/2012US20120282300 Protein biomaterials and biocoacervates and methods of making and using thereof
11/08/2012US20120282296 Methods for improving the design, bioavailability, and efficacy of directed sequence polymer compositions via serum protein-based detection of directed sequence polymer compositions
11/08/2012US20120282285 Masp isoforms as inhibitors of complement activation
11/08/2012US20120282276 Biomarkers predictive of progression of fibrosis
11/08/2012US20120282272 Novel target in the treatment of cytokine release syndrome
11/08/2012US20120282271 Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
11/08/2012US20120282261 Deuterated analogs of (4S)-4-Ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3', 4':6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereof
11/08/2012US20120282255 Methods and compositions for the treatment of alcoholism and alcohol dependence
11/08/2012US20120282253 Interleukin-10 antibodies
11/08/2012US20120282243 Soy sauce having hypotensive effects and method for producing the same
11/08/2012US20120282242 Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
11/08/2012US20120282241 Method of Treating Persistent Genital Arousal Disorder with a Neurotoxin
11/08/2012US20120282240 Thrombin isolated from blood and blood fractions
11/08/2012US20120282239 Novel mannanase variants
11/08/2012US20120282238 Use of Secreted Phospholipases A2 in the Diagnosis and Treatment of Malaria
11/08/2012US20120282237 Use of protein arginine methyltransferases in regulating hematopoietic differentiation
11/08/2012US20120282236 Method of delivering oxygen using peg-hemoglobin conjugates with enhanced nitrite reductase activity
11/08/2012US20120282235 Implantable patch and surgical kit for preparation thereof
11/08/2012US20120282231 Human lysosomal proteins from plant cell culture
11/08/2012US20120282230 Methods and compositions for diagnosis and treatment of genetic and retinal disease
11/08/2012US20120282227 Methods and compositions for the induction of hypothermia
11/08/2012US20120282226 Tissue Products Derived From Animals Lacking Any Expression of Functional Alpha 1, 3 Galactosyltransferase
11/08/2012US20120282224 Markers associated with ribavirin-induced anemia
11/08/2012US20120282223 Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid
11/08/2012US20120282222 Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases
11/08/2012US20120282221 Bromo-phenyl substituted thiazolyl dihydropyrimidines
11/08/2012US20120282220 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
11/08/2012US20120282219 Peptidomimetic protease inhibitors
11/08/2012US20120282218 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
11/08/2012US20120282217 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
11/08/2012US20120282216 Composition and Method for Treating Cancer
11/08/2012US20120282215 Vaccination of Cancer Patients
11/08/2012US20120282211 Antibodies and conjugates for modulators of angiogenesis
11/08/2012US20120282198 Cosmetic and/or pharmaceutical composition comprising an extract of carob as active agent for activating aquaporin expression
11/08/2012US20120282196 Smoothened polypeptides and methods of use
11/08/2012US20120282184 Treatment of obesity
11/08/2012US20120282172 Targeted delivery to human diseases and disorders
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012CA2838046A1 Induction of il-12 using immunotherapy
11/08/2012CA2838041A1 Methods for handling biological drugs containing living cells
11/08/2012CA2835105A1 Hepatitis c virus inhibitors
11/08/2012CA2834788A1 Cochleate compositions and methods of making and using same
11/08/2012CA2834776A1 Vascular disruption agents and uses thereof
11/08/2012CA2833931A1 Complement factor b analogs and their uses
11/08/2012CA2832464A1 Novel agonists and antagonists of the urotensinergic system
11/08/2012CA2831340A1 Excipient compatibility with ezatiostat
11/07/2012EP2520654A1 Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
11/07/2012EP2520652A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associates genes
11/07/2012EP2520587A2 Oxidant resistant apolipoprotein A-1 and mimetic peptides
11/07/2012EP2520309A1 Compositions and methods for soft tissue augmentation
11/07/2012EP2520308A1 Composition for improving brain function and method for improving brain function
11/07/2012EP2520302A1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
11/07/2012EP2520281A2 Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof
11/07/2012EP2520168A1 Targeted gene delivery for dendritic cell vaccination
11/07/2012EP2519251A2 Purified bowman-birk protease inhibitor proteins isolated from a soy processing stream
11/07/2012EP2519250A1 Interferon analogs
11/07/2012EP2519249A1 Methods for performing a coronary artery bypass graft procedure
11/07/2012EP2519248A1 Methods for the prevention or treatment of vessel occlusion injury
11/07/2012EP2519247A1 Topical acyl glutathione formulations
11/07/2012EP2519246A1 Topical acyl glutathione psoriasis formulations
11/07/2012CN1911960B Chlamydia protein, gene sequence and uses thereof
11/07/2012CN1524088B A virus causing respiratory tract illness in susceptible mammals
11/07/2012CN1505525B Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
11/07/2012CN102770458A Compositions and methods for increasing serum half-life of Fc fusion proteins
11/07/2012CN102770454A Activatable constructs
11/07/2012CN102770449A Factor VIII molecules with reduced vWF binding
11/07/2012CN102770442A Cyclic peptides for the regulation of vectorial ion channels
11/07/2012CN102770153A Long-acting insulin analogue preparations in soluble and crystalline forms
11/07/2012CN102770152A Mucosal delivery of peptides
11/07/2012CN102770151A Swallowable capsule and method for stimulating incretin production within the intestinal tract
11/07/2012CN102766668A Factor VII glycoforms
11/07/2012CN102766616A Thrombin isolated from blood and blood fractions
1 ... 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 ... 3163